pharma · Glaucoma · Macular Edema
Allergan Pharmaceuticals International
Allergan Pharmaceuticals International Limited
Allergan Pharmaceuticals International trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Dublin, IE HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, IE
- Programs
- 13
- Drugs
- 15
- Patents
- 25
Allergan Pharmaceuticals International clinical trials
Registry index of 18 ClinicalTrials.gov studies linked to Allergan Pharmaceuticals International programs — each row shows trial ID, program name, phase, status, and indication.
Allergan Pharmaceuticals International trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Allergan Pharmaceuticals International.
-
Placebo — Phase 3
Clinical update -
Gatifloxacin 0.3% ophthalmic solution — Phase 2
Clinical update -
Brimo PS DDS® — Phase 2
Clinical update -
botulinum toxin Type A — Phase 3
Clinical update -
botulinum toxin type A — Phase 2
Clinical update -
botulinum toxin Type A — Phase 2
Clinical update -
bimatoprost ophthalmic solution formulation A — Phase 3
Clinical update -
Abicipar Pegol — Phase 3
Clinical update